Serum Institute Of Technology Seeks Clearance For Covisheild

• ByStartupStory     |    June 29, 2021

Serum Institute of Technology seeks clearance for Covisheild from European Government. Serum Institute of India‘s CEO Adar Poonawalla Monday said he has taken the issue of recognition of the Covishield doses by the European regulators “at the highest levels and hope to resolve this matter soon, both with regulators and at a diplomatic level with countries” This came in after tourists and many other citizens of India faced problem while applying for European visa, they were said that if they have been injected with Covishield vaccine, it will not be considered as a proper vaccine. This seems problematic for many Indians who have taken Covishield,and for the majority both doses of Covershield have been completed. The European Medicines Agency, as it stands, recognises AstraZeneca shot made in the UK and Europe for the “Green Pass’ ‘ permit to travellers.

SII has now applied for recognition, Mint reports. Poonawalla is reported to have written to the Indian government too to push the case.Only four vaccines – Comirnaty of Pfizer/BioNTech, Moderna, Vaxzervria by AstraZeneca-Oxford and Johnson & Johnson’s Janssen – have been approved by the European Medicines Agency. “India has a large population. However, not including Covishield into the EU COVID-19 Vaccination Passport will not allow Covishield vaccinated people to travel to European countries and this will affect students, business travellers back and forth, and cause severe disruptions to our economy and to the global economy,” a source quoted Adar C Poonawalla, CEO of SII, as having communicated in a letter to External Affairs Minister S Jaishankar. Sources said referring to Poonawalla’s letter, Director, Government and Regulatory Affairs at SII, Prakash Kumar Singh, has also sought Jaishankar’s intervention at the highest level, saying, “It will be in the national interest as well as in the interest of people at large globally if Covishield vaccine is included in the EU COVID-19 Vaccination Passport.”

Follow Startup Story